Rachmühl, Carole
Lacroix, Christophe
Giorgetti, Ambra
Stoffel, Nicole U.
Zimmermann, Michael B.
Brittenham, Gary M.
Geirnaert, Annelies
Funding for this research was provided by:
Swiss Federal Institute of Technology Zurich
Article History
Received: 3 February 2023
Accepted: 27 June 2023
First Online: 4 July 2023
Declarations
:
: The study was part of the clinical trial “Prebiotic GOS and Lactoferrin for Beneficial Gut Microbiota With Iron Supplements” registered at clinicaltrials.gov as NCT03866837. The Ethics Commission of ETH Zürich, Switzerland (EK 2019-N-04) and the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (SERU) (KEMRI/RES/7/3/1 no.656) and the Columbia University Institutional Review Boards (IRB), USA (IRB-AAAR8900) reviewed and approved this study. Informed consent was obtained from the parents or the legal guardians of the infants. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.